Egyptian AI-powered Screening Startup DilenyTech Acquired By US-based Astute
Astute Imaging LLC, a provider of image-guided therapy based in the United States, announced the acquisition of Cairo-based HealthTech and AI-powered deep technology screening company DilenyTech. Astute Imaging will be able to utilize the power of AI to enhance its present offering, extend services, and develop innovative solutions in the medical imaging area as a result of the acquisition.
Dileny Technology (DilenyTech) is a forward-thinking startup that develops and installs cutting-edge artificial intelligence (AI) technologies to streamline radiology operations. It focuses on applications for medical imaging analysis, risk assessment for breast cancer, and structured reporting for a variety of medical applications.
This acquisition represents a significant milestone for the Cairo-based startup, as it merges with Astute Imaging, a healthcare information technology solutions company focused on developing disruptive artificial intelligence solutions to advance image-guided therapy and procedure planning in cardiovascular and interventional radiology.
Read also Ugandan Telemedicine Platform Rocket Health Raises $5m For East African Expansion
Astute Imaging is concentrating its efforts on using cutting-edge artificial intelligence and cloud technologies in order to enhance its patented imaging software and enable precision medicine for healthcare professionals and device manufacturers.
DilenyTech created a number of vendor-neutral AI-based proprietary technologies for radiology workflows, with a particular emphasis on women’s health. The company was recently given a US patent for its revolutionary artificial intelligence (AI) technology in medical imaging and has supplied services to a number of leading worldwide healthcare companies and medical organizations.
“This strategic acquisition of DilenyTech will enable Astute Imaging to expedite the development of an AI-driven image-guided therapy platform and add more automation to our imaging services and procedure planning solutions,” Wael Elseaidy, co-founder and CEO of Astute Imaging, stated. “Empowering our surgery planning and patient follow-up imaging platforms with AI will help our customers and medical imaging stakeholders to provide more patient-centric proactive services.”
Astute Imaging plans to introduce an AI-powered aorta tracking tool to empower providers with proactive patient-centric services. For medical device makers, Astute Imaging plans to integrate AI into its imaging core lab and procedure planning services to provide seamless workflow and device tracking.
“This acquisition will help Astute Imaging to expedite the introduction of AI into its cloud-based platform for image-guided therapy and workflow automation utilizing millions of procedure data assets to drive faster and enhanced services.” Ewald de Vries, co-founder, and Astute imaging CTO indicated. “Incorporating AI into our cloud-based alert management system and creating data-driven predictive algorithms for procedure planning will make our offering very powerful and unique.”
Additionally, Astute imaging intends to create and offer predictive models for cardiovascular case planning, as well as to extend into new sectors such as women’s health and cancer therapy. Predictive models will assist businesses in gaining a better understanding of future advancements to interventional devices used in image-guided treatments, particularly in the cardiovascular and cancer sectors.
“We are excited to be part of Astute Imaging’s amazing team and adopt our expertise and technologies to build reliable AI technologies for imaging-guided therapy,” said Ahmed Ehab Mahmoud, DilenyTech founder and innovation director who will be joining Astute Imaging’s founding team and managing the imaging operations. “We have applied our technologies successfully in the area of breast imaging and we look forward to expanding our AI pipeline to other imaging areas such as thyroid, liver, and gynecology as well as cardiovascular 3D imaging and procedural planning. We believe Astute Imaging will be a game-changer for healthcare providers and device companies.”
Read also How a common network security technology stack aligns IT & Cybersecurity
DilenyTech was founded in 2018 by Ahmed Ehab Mahmoud.
Charles Rapulu Udoh
Charles Rapulu Udoh is a Lagos-based lawyer who has advised startups across Africa on issues such as startup funding (Venture Capital, Debt financing, private equity, angel investing etc), taxation, strategies, etc. He also has special focus on the protection of business or brands’ intellectual property rights ( such as trademark, patent or design) across Africa and other foreign jurisdictions.
He is well versed on issues of ESG (sustainability), media and entertainment law, corporate finance and governance.
He is also an award-winning writer